• #544446
  • 394
  • Merck #00006404741

RotaTeq® Rotavirus Vaccine 6 to 32 Weeks of Age Suspension Single Dose Tube 2 mL

ROTATEQ VAC, SUSP 2ML LIVE PENTAV (10/PK)

Features
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • 10 individually pouched single dose tubes
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
  • More …
  Log In to Order
or
 View Alternatives

Professionals Also Viewed

Glaxo Smith Kline 58160085452

  • #775513
  • 123
  • Glaxo Smith Kline #58160085452
Rotarix® Rotavirus Vaccine Infants 6 to 24 Weeks of Age 10E6 / mL Suspension Prefilled Oral Applicator 1 mL

  • Administer first dose to infants beginning at 6 weeks of age
  • Administer second dose after an interval of at least 4 weeks and prior …
  • Vial of lyophilized vaccine to be reconstituted with accompanying liqu …
Merck 00006404720

  • #1030987
  • 37
  • Merck #00006404720
RotaTeq® Rotavirus Vaccine Indicated for Patients 6 to 32 Weeks of Age Solution Single Dose Tube 2 mL

  • RotaTeq® is a vaccine indicated for the prevention of rotavirus gastro …
  • RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
  • The vaccination series consists of three ready-to-use liquid doses of …

Product Specifications

McKesson #544446
Manufacturer #00006404741
BrandRotaTeq®
ManufacturerMerck
Country of OriginUnited States
ApplicationRotavirus Vaccine
Container TypeSingle Dose Tube
Dosage FormSuspension
Generic Drug Code26500
Generic Drug NameRotavirus Vaccine, Live, Pentavalent
NDC Number00006-4047-41
Product DatingMcKesson Acceptable Dating: we will ship >= 180 days
Storage RequirementsRequires Refrigeration
TypeOral
UNSPSC Code51201618
User6 to 32 Weeks of Age
Volume2 mL
Features
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • 10 individually pouched single dose tubes
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
More Information